FDA Slaps Indiana Compounder Over Sterile Drug Lapses
The Guyer Institute of Molecular Medicine, an Indianapolis, Ind.-based drug compounder, has drawn a warning letter from the FDA for its sterile drug production.
Source: Drug Industry Daily
The Guyer Institute of Molecular Medicine, an Indianapolis, Ind.-based drug compounder, has drawn a warning letter from the FDA for its sterile drug production.
Source: Drug Industry Daily